1. Home
  2. ELDN vs BDMD Comparison

ELDN vs BDMD Comparison

Compare ELDN & BDMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • BDMD
  • Stock Information
  • Founded
  • ELDN 2004
  • BDMD 2012
  • Country
  • ELDN United States
  • BDMD China
  • Employees
  • ELDN N/A
  • BDMD N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • BDMD
  • Sector
  • ELDN Health Care
  • BDMD
  • Exchange
  • ELDN Nasdaq
  • BDMD NYSE
  • Market Cap
  • ELDN 178.4M
  • BDMD 196.9M
  • IPO Year
  • ELDN N/A
  • BDMD N/A
  • Fundamental
  • Price
  • ELDN $2.89
  • BDMD $5.18
  • Analyst Decision
  • ELDN Strong Buy
  • BDMD
  • Analyst Count
  • ELDN 1
  • BDMD 0
  • Target Price
  • ELDN $16.00
  • BDMD N/A
  • AVG Volume (30 Days)
  • ELDN 160.2K
  • BDMD 34.2K
  • Earning Date
  • ELDN 05-20-2025
  • BDMD 01-01-0001
  • Dividend Yield
  • ELDN N/A
  • BDMD N/A
  • EPS Growth
  • ELDN N/A
  • BDMD 4212.17
  • EPS
  • ELDN N/A
  • BDMD 0.43
  • Revenue
  • ELDN N/A
  • BDMD $33,048,249.00
  • Revenue This Year
  • ELDN N/A
  • BDMD N/A
  • Revenue Next Year
  • ELDN N/A
  • BDMD N/A
  • P/E Ratio
  • ELDN N/A
  • BDMD $12.07
  • Revenue Growth
  • ELDN N/A
  • BDMD 11.28
  • 52 Week Low
  • ELDN $2.00
  • BDMD $1.05
  • 52 Week High
  • ELDN $5.54
  • BDMD $13.52
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 40.93
  • BDMD N/A
  • Support Level
  • ELDN $2.85
  • BDMD N/A
  • Resistance Level
  • ELDN $3.51
  • BDMD N/A
  • Average True Range (ATR)
  • ELDN 0.27
  • BDMD 0.00
  • MACD
  • ELDN -0.01
  • BDMD 0.00
  • Stochastic Oscillator
  • ELDN 5.63
  • BDMD 0.00

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Share on Social Networks: